Ausgabe 6/2020
Inhalt (24 Artikel)
SEOR recommendations on the use of protons
M. Lloret-Saez-Bravo, J. Giralt-L de Sagredo, J. Contreras-Martinez, C. Ferrer-Albiach
A spotlight on cancer researchers in Spain: new paradigms and disruptive ideas
S. Ramón y Cajal, P. Sancho, L. Soucek, H. Peinado, M. Abad, M. Valiente, A. Efeyan, J. Pardo, V. Quesada, J. Jimeno, P. M. Duque, A. Antón, I. Varela, A. J. Schuhmacher
Ethical commitment of Spanish oncologists to patients with prostate cancer: reflections on the statements of the new ASTRO/AUA guideline (2019 guideline amendment)
F. Casas, G. Oses, K. S. Cortes, T. D. Barreto, D. Muñoz
The utilization of saliva as an early diagnostic tool for oral cancer: microRNA as a biomarker
J. S. Ghizoni, R. Nichele, M. T. de Oliveira, S. Pamato, J. R. Pereira
Prevalence, prognosis and predictive status of HER2 amplification in anti-EGFR-resistant metastatic colorectal cancer
G. Wang, Y. He, Y. Sun, W. Wang, X. Qian, X. Yu, Y. Pan
Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo, R. Álvarez-Alegret
Prognostic role of interleukin-6 in renal cell carcinoma: a meta-analysis
Y. Wang, Y. Zhang
Osimertinib beyond disease progression in T790M EGFR-positive NSCLC patients: a multicenter study of clinicians’ attitudes
A. Cortellini, A. Leonetti, A. Catino, P. Pizzutillo, B. Ricciuti, A. De Giglio, R. Chiari, P. Bordi, D. Santini, R. Giusti, M. De Tursi, D. Brocco, F. Zoratto, F. Rastelli, F. Citarella, M. Russano, M. Filetti, P. Marchetti, R. Berardi, M. Torniai, D. Cortinovis, E. Sala, C. Maggioni, A. Follador, M. Macerelli, O. Nigro, A. Tuzi, D. Iacono, M. R. Migliorino, G. Banna, G. Porzio, K. Cannita, M. G. Ferrara, E. Bria, D. Galetta, C. Ficorella, M. Tiseo
Identifying the incidence of respiratory complications following diaphragmatic cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy
P. Cascales Campos, L. A. Martinez Insfran, D. Wallace, J. Gil, E. Gil, A. Gonzalez Gil, J. Martínez, J. L. Alonso Romero, R. Gonzalez Sanchez, P. Parrilla
Important prognostic factors in leiomyosarcoma survival: a National Cancer Database (NCDB) analysis
J. Gootee, N. Sioda, S. Aurit, C. Curtin, P. Silberstein
Circulating tumour cells and hypercoagulability: a lethal relationship in metastatic breast cancer
C. C. Kirwan, T. Descamps, J. Castle
Outcomes of extraskeletal vs. skeletal Ewing sarcoma patients treated with standard chemotherapy protocol
S. Salah, F. Abuhijla, T. Ismail, S. Yaser, I. Sultan, H. Halalsheh, A. Shehadeh, S. Abdelal, A. Almousa, O. Jaber, R. Abu-Hijlih
TLI in pediatric patients
A. Ocanto, A. Escribano, L. Glaría, I. Rodríguez, C. Ferrer, C. Huertas, A. Pérez, R. Morera
Efficacy of osimertinib for the treatment of previously EGFR TKI treated NSCLC patients: a meta-analysis
Z.-X. Li, W. Zhao, Q. Sun, M.-S. Tang, Q.-J. Xia, M.-S. Dong
Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma
F. Consoli, M. Bersanelli, G. Perego, S. Grisanti, B. Merelli, A. Berruti, F. Petrelli
Detection of novel mitochondrial mutations in cytochrome C oxidase subunit 1 (COX1) in patients with familial adenomatous polyposis (FAP)
E. Afkhami, M. M. Heidari, M. Khatami, F. Ghadamyari, S. Dianatpour
Safety and efficacy of PD-1/PD-L1 blockade in patients with preexisting antinuclear antibodies
T. Sakakida, T. Ishikawa, Y. Chihara, S. Harita, J. Uchino, Y. Tabuchi, S. Komori, J. Asai, T. Narukawa, A. Arai, H. Tsunezuka, T. Kosuga, H. Konishi, M. Moriguchi, H. Yasuda, F. Hongo, M. Inoue, S. Hirano, O. Ukimura, Y. Itoh, T. Taguchi, K. Takayama
Dynamic monitoring of HER2 amplification in circulating DNA of patients with metastatic colorectal cancer treated with cetuximab
R. Liu, X. Zhao, W. Guo, M. Huang, L. Qiu, W. Zhang, Z. Zhang, W. Li, X. Zhu, Z. Chen
Increased survival time or better quality of life? Trade-off between benefits and adverse events in the systemic treatment of cancer
V. Valentí, J. Ramos, C. Pérez, L. Capdevila, I. Ruiz, L. Tikhomirova, M. Sánchez, I. Juez, M. Llobera, E. Sopena, J. Rubió, R. Salazar
Detection of incident breast and colorectal cancer cases from an administrative healthcare database in Catalonia, Spain
J. M. Escribà, M. Banqué, F. Macià, J. Gálvez, L. Esteban, L. Pareja, R. Clèries, X. Sanz, X. Castells, J. M. Borrás, J. Ribes
Standardized versus research-based PAM50 intrinsic subtyping of breast cancer
A. Prat, J. S. Parker
Comment on “Prognostic factors and survival in Ewing’s sarcoma treated by limb salvage surgery”
J. Weng, M. Xie, Z. Xu, Z. Wang
Treatment of radiation-induced myelopathy with bevacizumab
G. Cañedo, I. Solis, C. González-San Segundo, L. Madero, A. Lassaletta
Correction to: Liquid biopsy in oncology: a consensus statement of the Spanish Society of Pathology and the Spanish Society of Medical Oncology
J. Remon, R. García-Campelo, E. de Álava, R. Vera, J. L. Rodríguez-Peralto, Á. Rodríguez-Lescure, B. Bellosillo, P. Garrido, F. Rojo, R. Álvarez-Alegret